Prevalence of COVID-19 in a French Dependent Care Facility for the Elderly and in a French Long-term Care Unit: Observational Study
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 150
- 试验地点
- 1
- 主要终点
- General prevalence of COVID-19
研究概览
简要总结
The aim of this study is to evaluate the prevalence of COVID-19 among the residents and geriatric inpatients of the care facilities attached to the Centre Hospitalier Sud Essonne (a general hospital located in Ile-de-France, France), and the factors that are likely to influence this prevalence.
详细描述
Among people exposed to the COVID-19 (SARS-COV-2) pandemic, elderly people are considered as particularly vulnerable, especially those living in nursing homes or hospitalized. Furthermore, facilities / accommodations are registered among the main locations of COVID-19 clusters.
These observations have led the French government to establish specific protection measures and survey dependent care facilities for the elderly and long-term care units in the hospital.
With these new standards established, a long-term study of all the residents and geriatric inpatients of the care facilities attached to the Centre Hospitalier Sud Essonne (a general hospital located in Ile-de-France, France), can provide additional knowledge on COVID-19.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •residents of the dependant care facility for the elderly
- •inpatients of the long-term care unit
- •from march, 2020 to december, 2021
排除标准
- •opposition to participate in this study
结局指标
主要结局
General prevalence of COVID-19
时间窗: Through the study completion, an average of 12 months
measures the prevalence of COVID-19 among the residents and geriatric inpatients, defined as resident and patients with positive serologic or RT-PCR test
次要结局
- Number of symptomatic residents/inpatients(Through study completion, an average of 12 months)
- Number of residents/inpatients vaccinated against COVID-19(Through study completion, an average of 12 months)
- Number of asymptomatic residents/inpatients(Through study completion, an average of 12 months)
- Number of residents/inpatients infected with COVID-19 and deceased(Through study completion, an average of 12 months)
- Influencing factors of the prevalence of COVID-19 among residents/inpatients(Through study completion, an average of 12 months)
- Number of residents/inpatients infected with COVID-19 and hospitalized in a critical care unit(Through study completion, an average of 12 months)
- Number of residents/inpatients with severe form of COVID-19 which led to an hospitalization(Through study completion, an average of 12 months)
